This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Things to Note Before Estee Lauder Companies' (EL) Q2 Earnings
by Zacks Equity Research
The Estee Lauder Companies' (EL) second-quarter performance will likely reflect incremental external headwinds like economic hurdles in China and unfavorable foreign currency fluctuations.
Church & Dwight (CHD) Gears up for Q4 Earnings: What to Note?
by Zacks Equity Research
Church & Dwight (CHD) is likely to have seen growth in Q4 earnings, supported by strategic initiatives and consumer demand despite the potential impacts of increased expenses.
Seeking Clues to Church & Dwight (CHD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Church & Dwight (CHD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Things to Note Before Post Holdings' (POST) Q1 Earnings
by Zacks Equity Research
Post Holdings' (POST) first-quarter fiscal 2024 earnings are likely to reflect gains from strategic buyouts and effective pricing actions.
Mondelez (MDLZ) Q4 Earnings Coming Up: Factors to Consider
by Zacks Equity Research
Mondelez's (MDLZ) fourth-quarter performance is likely to reflect gains from strength in snacking business and emerging market.
Colgate (CL) Q4 Earnings & Sales Beat Estimates, '24 View Issued
by Zacks Equity Research
Colgate's (CL) Q4 results benefited from strong sales growth, robust organic volume growth and gross and operating margin expansion.
Church & Dwight (CHD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate-Palmolive (CL) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.35% and 1.06%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Sysco Corporation's (SYY) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Sysco's (SYY) second-quarter results are likely to reflect gains from supply-chain productivity and structural cost-containment efforts.
McCormick (MKC) Q4 Earnings Coming Up: Factors to Consider
by Zacks Equity Research
McCormick's (MKC) fourth-quarter performance is likely to reflect gains from pricing actions and cost savings. Focus on the GOE programs is likely to contribute to the upside.
Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
Colgate (CL) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2023 performance is likely to have gained from solid consumer demand and efforts related to innovation, premiumization and digital transformation.
Things to Consider Before Kimberly-Clark's (KMB) Q4 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) fourth-quarter performance is likely to reflect gains from revenue growth management and cost-saving efforts amid inflationary headwinds.
Why Church & Dwight (CHD) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Stocks Set to Grow in the Thriving Soap & Cleaning Materials Industry
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on favorable demand trends, pricing efforts, innovation, digital transformation and brand building amid elevated costs. Players like PG, CL, CHD and CLX look well-poised.
Can Pricing, Demand Shield Church & Dwight (CHD) From Cost Woes?
by Zacks Equity Research
Church & Dwight (CHD) gains on solid consumer demand due to its consistent innovation and acquisitions. This, along with efficient pricing, helps the company amid high SG&A costs.
Church & Dwight (CHD) Gains on Portfolio Strength Amid Cost Woes
by Zacks Equity Research
Brand strength, efficient pricing and productivity gains work well for Church & Dwight (CHD) amid cost inflation and high SG&A expenses.
Under Armour (UAA) Lined for Q2 Earnings: Here's What to Expect
by Zacks Equity Research
Under Armour's (UAA) second-quarter fiscal 2024 results are likely to reflect the impacts of a tough operating landscape and adverse currency fluctuations.
Compared to Estimates, Church & Dwight (CHD) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Church & Dwight (CHD) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Church & Dwight (CHD) Beats Q3 Earnings Estimate, Ups Sales View
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2023 results reflect lower earnings while sales increase year over year. Management pulls up 2023 top-line guidance.
Church & Dwight (CHD) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 8.82% and 1.61%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Church & Dwight (CHD) This Earnings Season?
by Zacks Equity Research
Church & Dwight (CHD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Medifast (MED) Queues for Q3 Earnings: What Awaits the Stock?
by Zacks Equity Research
Medifast's (MED) third-quarter results are likely to reflect concerns surrounding customer acquisition amid a challenging landscape. However, a focus on growth plans bodes well.
Steven Madden's (SHOO) Q3 Earnings Coming Up: What to Expect
by Zacks Equity Research
Steven Madden's (SHOO) third-quarter 2023 results are likely to be hurt by a challenging macroeconomic landscape and higher expenses.
Church & Dwight (CHD) Queues for Q3 Earnings: Is a Beat Likely?
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter results are likely to reflect gains from pricing, acquisitions and favorable demand amid high SG&A expenses.